Markets are efficient where it pays someone to make them efficient. Below ₹2,000 crore of market value, it mostly doesn’t — and that single economic fact explains more about India’s small and micro-cap opportunity than any growth statistic.
The coverage economics
Sell-side research is paid for, directly or indirectly, by trading volumes and banking fees. A company with thin float and modest volumes cannot generate either, so it gets no analyst — regardless of how fast its earnings compound. The result is a universe of hundreds of listed Indian companies growing earnings at multiples of the large-cap rate whose public information is limited to statutory filings. Price discovery in these names runs on retail sentiment and promoter action, not on institutional research.
The ownership rules
Institutional capital faces size thresholds that are mechanical, not analytical: minimum float requirements, index-eligibility rules, internal liquidity mandates that forbid positions above a share of daily volume. A fund managing thousands of crores cannot own a ₹800 crore company in any size that matters to its portfolio — so it doesn’t look. The consequence is that institutional ownership in the SMID universe sits far below large-cap levels, and the marginal buyer is systematically less informed.
What changes — and when
The inefficiency resolves company by company, through a repeatable sequence: earnings scale → float and volumes deepen → a first broker initiates coverage → index eligibility approaches → institutions arrive with size. Each step re-prices the stock, because each step changes who is allowed to own it. Over the last five years this dynamic — compounding earnings plus the adoption re-rating — has produced roughly three times the large-cap return in USD terms at the index level.
The honest caveats
The same structure that creates the mispricing creates the risk. Thin liquidity cuts both ways: it discounts the entry and can trap the exit. Governance quality is dispersed — the universe contains both the next decade’s mid-caps and companies that should never have listed, and the difference is usually the promoter. Drawdowns are wider, and a broad SMID de-rating (2024–25 provided a reminder) can suspend the adoption sequence for quarters at a time. This is why Novem’s process spends its heaviest stages on promoter and governance review, and why position sizing is bounded by realistic exit capacity rather than conviction.
The conclusion is not that small is beautiful. It is that under-owned and under-researched is exploitable — for capital that does its own research, enters before the adoption sequence, and sizes positions for the liquidity that exists rather than the liquidity it hopes for.